Hematology is a branch of medicine, which involves the study and treatment of blood. This is concerned with the diagnosis, study, treatment, and prevention of diseases related to blood. However, for the hematology study, the flow cytometry instrument is required to conduct study related to the blood. Flow cytometry analyzes the whole blood component, i.e., physical and chemical characteristics of the particles present in the blood. Flow cytometry is a laser-based biophysical technology involved in the cell sorting, cell counting, protein detection, and biomarker detection. Flow cytometry analyzes fluid by suspending fluid in the light beam or laser beam. Cell components in the fluid are fluorescently labeled and then they are passed through beam which later on excited by the laser to emit light at diversified wavelengths. The fluorescence lights help to determine various properties of single particles and cells from different wavelengths. Flow cytometer analyzes up to thousands of particles per second as the beam passes through the liquid stream.

Global hematology and flow cytometry market has been segmented by product, technology, application, and by end-user. On the basis of product, the hematology and flow cytometry market is segmented into flow cytometry instruments, reagent & consumables, and accessories. The flow cytometry instruments segment is further classified into cell analyzers and cell sorters. Based on technology, the hematology and flow cytometry market is categorized into bead-based flow cytometry and cell-based flow cytometry. The cell-based flow cytometry segment is expected to hold a large share of the market owing to its speed and accuracy. On the basis of end-user, the market is segmented into biotechnology and pharmaceutical companies, hospitals, clinics, research centers, clinical testing laboratories, academics, and others. The clinical testing laboratories segment is expected to grow at a rapid rate in the near future owing to the increase in prevalence of the various diseases in which flow cytometry is required for diagnosis. The biotechnology and pharmaceutical companies segment hold a significant share of the hematology and flow cytometry market due to growth in research and development activity.

Geographically, the hematology and flow cytometry market has been classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America has dominated the market and is expected to be at the forefront in the next few years. The considerable share of North America is attributable to increase in the demand for improved efficiency. Moreover, government initiatives in the region has fueled the market growth. North America is followed by Europe. The Europe region is estimated to register a higher growth in the near future. Increasing geriatric population is responsible for the growth rate in Europe. Emerging markets such as Asia Pacific, Latin America, and Middle East & Africa are expected to record lucrative growth during the forecast period. China, Brazil, and India are expected to drive the strong growth of the market due to increase in investments by government bodies to enhance health care facilities.

In addition, there are number of factors that are expected to affect the growth of the market such as continuous advancements in molecular diagnostics, monoclonal antibodies, lasers and software. Moreover, growth in demand for understanding of immunologic regulating systemic diseases and increase in adoption rate by health care facilities are anticipated to drive growth of the market in the near future. The introduction of smaller and easy-to-operate laser systems is likely to boost the hematology and flow cytometry market in the near future.

Major players operating in this market include Becton, Dickinson and Company, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, and Sony Biotechnology.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Hematology Flow Cytometry Market

Pre Book